AB
Abhilash Barpanda
UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco Medical Center
Research areas: Medicine · Oncology · Advanced Proteomics Techniques and Applications · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers
0000-0001-8158-4949
Employment
-
UCSF Helen Diller Family Comprehensive Cancer Center Post Doctoral Research Associate2023 - Present
-
UCSF Medical Center post doctoral researcher2023 - Present
- 2023 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer Save
- Molecular Signatures of Pyomelanin Production in MDR Acinetobacter baumannii: A Proteomic Perspective Save
- CELLULAR IMMUNOTHERAPY TARGETING CLL-1 FOR JUVENILE MYELOMONOCYTIC LEUKEMIA Save
- Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia Save
- Essential Role of Protein Kinase R in the Pathogenesis of Pulmonary Veno-occlusive Disease Save
- Essential role of protein kinase R in the pathogenesis of pulmonary veno-occlusive disease Save
- Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity Save
- Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer Save
- Optimized anti-CD70 CAR-T cells for high-risk multiple myeloma Save
- Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells Save
- Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets Save
- Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens across cancers Save
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens Save
- Unbiased in-depth surfaceome profiling of Acute Myeloid Leukemia reveals novel immunotherapy targets beyond canonical membrane proteins Save
- A multi-subunit autophagic capture complex facilitates degradation of ER stalled MHC-I in pancreatic cancer. Save
- Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types Save
- TUMOR-WIDE RNA SPLICING ABERRATIONS GENERATE IMMUNOGENIC PUBLIC NEOANTIGENS IN GLIOBLASTOMAS AND OTHER CANCER TYPES Save
- Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells Save
- A protein microarray-based serum proteomic investigation reveals distinct autoantibody signature in colorectal cancer Save
- Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel Save